Cargando…
Pharmacoepidemiology for nephrologists (part 2): potential biases and how to overcome them
Observational pharmacoepidemiological studies using routinely collected healthcare data are increasingly being used in the field of nephrology to answer questions on the effectiveness and safety of medications. This review discusses a number of biases that may arise in such studies and proposes solu...
Autores principales: | Fu, Edouard L, van Diepen, Merel, Xu, Yang, Trevisan, Marco, Dekker, Friedo W, Zoccali, Carmine, Jager, Kitty, Carrero, Juan Jesus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087121/ https://www.ncbi.nlm.nih.gov/pubmed/33959262 http://dx.doi.org/10.1093/ckj/sfaa242 |
Ejemplares similares
-
Pharmacoepidemiology for nephrologists (part 1): concept, applications and considerations for study design
por: Trevisan, Marco, et al.
Publicado: (2020) -
External validation of prognostic models: what, why, how, when and where?
por: Ramspek, Chava L, et al.
Publicado: (2020) -
Conducting correlation analysis: important limitations and pitfalls
por: Janse, Roemer J, et al.
Publicado: (2021) -
A new series of advanced-level research methods papers
por: Jager, Kitty J, et al.
Publicado: (2020) -
The long-term benefits of early intensive therapy in chronic diseases—the legacy effect
por: Zoccali, Carmine, et al.
Publicado: (2023)